JOEL JOHNS, MD

Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use

Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes

Established patient office or other outpatient visit, 40-54 minutes

Hospital discharge day management, more than 30 minutes

Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit

Established patient office or other outpatient visit, 30-39 minutes

Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes

Influenza vaccine split virus, preservative free

Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and

Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or

Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a

Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report

Administration of pneumococcal vaccine

Injection of drug or substance under skin or into muscle

Administration of influenza virus vaccine

Hemoglobin a1c level

Insertion of needle into vein for collection of blood sample